Abstract
Oxidative stress leads to the induction of cellular oxidative damage, which may cause adverse modifications of DNA, proteins, and lipids. The production of reactive species during oxidative stress contributes to the pathogenesis of many diseases. Antioxidant defenses can neutralize reactive oxygen species and protect against oxidative damage. The aim of this study was to assess the antioxidant status and the degree of DNA damage in Korean young adults using glutathione s-transferase (GST) polymorphisms. The GSTM1 and GSTT1 genotypes were characterized in 245 healthy young adults by smoking status, and their oxidative DNA damage in lymphocytes and antioxidant status were assessed by GST genotype. General characteristics were investigated by simple questionnaire. From the blood of the subjects, GST genotypes; degree of DNA damage in lymphocytes; the erythrocyte activities of superoxide dismutase, catalase, and glutathione peroxidase; plasma concentrations of total peroxyl radical-trapping potential (TRAP), vitamin C, α- and γ-tocopherol, α- and β-carotene and cryptoxanthin, as well as plasma lipid profiles, conjugated diene (CD), GOT, and GPT were analyzed. Of the 245 subjects studied, 23.2% were GSTM1 wild genotypes and 33.4% were GSTT1 wild genotype. No difference in erythrocyte activities of superoxide dismutase, catalase, or glutathione peroxidase, and the plasma TRAP level, CD, GOT, and GPT levels were observed between smokers and non-smokers categorized by GSTM1 or GSTT1 genotype. Plasma levels of α- and γ-tocopherol increased significantly in smokers with the GSTT1 wild genotype (p < 0.05); however, plasma level of α-carotene decreased significantly in non-smokers with the GSTM1 wild genotype (p < 0.05). DNA damage assessed by the Comet assay was significantly higher in non-smokers with the GSTM1 null genotype; whereas DNA damage was significantly lower in non-smokers with the GSTT1 null genotype. Total cholesterol and LDL cholesterol levels were significantly higher in non-smokers with the GSTT1 null genotype than those with the GSTT1 wild genotype (p < 0.05). In conclusion, the GSTM1 null genotype or the GSTT1 wild genotype in non-smokers aggravated their antioxidant status through DNA damage of lymphocytes; however, the GSTT1 wild type in non-smokers had normal plasma total cholesterol and LDL-cholesterol levels. This finding confirms that GST polymorphisms could be an important determinant of antioxidant status and plasma lipid profiles in non-smoking young adults. Further study is necessary to clarify the antioxidant status and/or lipid profiles of smokers with the GST polymorphism and to conduct a study with significantly more subjects.
References
1. Marcon F, Andreoli C, Rossi S, Verdina A, Galati R, Crebelli R. Assessment of individual sensitivity to ionizing radiation and DNA repair efficiency in a healthy population. Mutat Res. 2003. 541(1-2):1–8.
2. Rollinson S, Roddam P, Kane E, Roman E, Cartwright R, Jack A, Morgan GJ. Polymorphic variation within the glutathione S-transferase genes and risk of adult acute leukaemia. Carcinogenesis. 2000. 21(1):43–47.
3. Park E, Kang MH. Smoking and high plasm triglyceride levels as risk factors for oxidative DNA damage in the Korean population. Ann Nutr Metab. 2004. 48:36–42.
4. Park YK, Park E, Kim JS, Kang MH. Daily grape juice consumption reduces oxidative DNA damage and plasma free radical levels in healthy Korean. Mutat Res. 2003. 529:77–86.
5. Sinha R, Caporaso N. Diet, genetic Susceptibility and human cancer etiology. J Nutr. 1999. 129:2S Suppl. 556S–559S.
6. Hoffmann H, Isner C, Högel J, Speit G. Genetic polymorphisms and the effect of cigarette smoking in the comet assay. Mutagenesis. 2005. 20(5):359–364.
7. Strange RC, Fryer AA. The glutathione S-transferase: Influence of polymorphism on cancer susceptibility. IARC Sci Publ. 1999. (148):231–249.
8. Rebbeck TR. Molecular epidemiology of the human glutathione S-transferase genotype GSTM1 and GSTT1 in cancer susceptibility. Cancer Epidemiol Biomarkers Prev. 1997. 6:733–743.
9. Ye Z, Song H. Glutathione s-transferase polymorphisms (GSTM1, GSTP1 and GSTT1) and the risk of acute leukaemia: a systematic review and meta-analysis. Eur J Cancer. 2005. 41(7):980–989.
10. Davies SM, Bhatia S, Ross JA, Kiffmeyer WR, Gaynon PS, Radloff GA, Robison LL, Perentesis JP. Glutathione S-transferase genotypes, genetic susceptibility, and outcome of therapy in childhood acute lymphoblastic leukemia. Blood. 2002. 100(1):67–71.
11. Masetti S, Botto N, Manfredi S, Colombo MG, Rizza A, Vassalle C, Clerico A, Biagini A, Andreassi MG. Interactive effect of the glutathione S-transferase genes and cigarette smoking on occurrence and severity of coronary artery risk. J Mol Med. 2003. 81(8):488–494.
12. Gawecki W, Kostrzewska-Poczekaj M, Gajecka M, Milecki P, Szyfter K, Szyfter W. The role of genetic factor in etiopathogenesis of squamous cell carcinoma of the head and neck in young adults. Eur Arch Otorhinolaryngol. 2007. 264:1459–1465.
13. Choi SC, Yun KJ, Kim TH, Kim HJ, Park SG, Oh GJ, Chae SC, Oh GJ, Nah YH, Kim JJ, Chung HT. Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression. Cancer Lett. 2003. 195(2):169–175.
14. Bouchardy C, Benhamou S, Jourenkova N, Dayer P, Hirvonen A. Metabolic genetic polymorphisms and susceptibility to lung cancer. Lung Cancer. 2001. 32(2):109–112.
15. Palma S, Cornetta T, Padua L, Cozzi R, Appolloni M, Ievoli E, Testa A. Influence of glutathione S-transferase polymorphisms on genotoxic effects induced by tobacco smoke. Mutat Res. 2007. 633:1–12.
16. Ketelslegers HB, Gottschalk RW, Godschalk RW, Knaapen AM, van Schooten FJ, Vlietinck RF, Kleinjans JC, van Delft JH. Interindividual variations in DNA adduct levels assessed by analysis of multiple genetic polymorphisms in smokers. Cancer Epidemiol Biomarkers Prev. 2006. 15(4):624–629.
17. Haase D, Binder C, Bünger J, Fonatsch C, Streubel B, Schnittger S, Griesinger F, Westphal G, Schoch C, Knopp A, Berkovicz D, Krieger O, Wörmann B, Hilgers R, Hallier E, Schulz T. Increased risk for therapy-associated hematologic malignancies in patients with carcinoma of the breast and combined homozygous gene deletions of glutathione transferases M1 and T1. Leuk Res. 2002. 26(3):249–254.
18. Zintzaras E. Glutathione S-transferase M1 and T1 genes and susceptibility to chronic myeloid leukemia: a meta-analysis. Genet Test Mol Biomarkers. 2009. 13(6):791–797.
19. McGrath M, Michaud D, De Vivo I. Polymorphisms in GSTT1, GSTM1, NAT1 and NAT2 genes and bladder cancer risk in men and women. BMC Cancer. 2006. 6:239.
20. Jeong JH, Kim JH, Seo YI, Kim JH, Oh GJ, Chae CS, Lim SJ, Chung TH, Kim JJ. Association between glutathione S-transferase M1 and T1 polymorphisms and increased risk for bladder cancer in Korean smokers. Cancer Lett. 2003. 202(2):193–199.
21. Jeon GI, Park E. Effect of glutathione S-transferase polymorphisms on the antioxidant system. J Korean Soc Food Sci Nutr. 2007. 36(6):708–719.
22. Bell DA, Taylor JA, Paulson DF, Robertson CN, Mohler JL, Lucier GW. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J Natl Cancer Inst. 1993. 85:1159–1164.
23. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, Ketter B, Taylor JB. Human glutathione S-transferase theta(GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J. 1994. 300(Pt 1):271–276.
24. Park EJ, Kim JS, Jeon EJ, Kim HY, Par YK, Kang MH. The effects of purple grape juice supplementation on improvement of antioxidant status and lymphocyte DNA damage in Korean smokers. Korean J Nutr. 2004. 37(4):281–290.
25. Kim JS, Park E, Min HS, Kang MH. Relationships of plasma homocysteine concentration and oxidative stress markers in Korean collage students. Korean J Nutr. 2010. 43(5):443–452.
26. Bertolotti M, Spady DK, Dietschy JM. Regulation of hepatic cholesterol metabolism in the rat in vivo. Biochim Biophys Acta. 1955. 1255:293–300.
27. Cho HJ, Lee SY, Ki CS, Kim JW. GSTM1, GSTT1 and GSTP1 Polymorphisms in the Korean Population. J Korean Med Sci. 2005. 20(6):1089–1092.
28. Choi SC, Yun KJ, Kim TH, Kim HJ, Park SG, Oh GJ, Chae SC, Nah YH, Kim JJ, Chung HT. Prognostic potential of glutathione S-transferase M1 and T1 null genotypes for gastric cancer progression. Cancer Lett. 2003. 195:169–175.
29. Jang SS, Jung CY, Lee SY, Lee JH, Jeon HS, park SH, Son JW, Lee EB, Kim CH, Kam S, Park RW, Kim IS, Jung TH, Park JY. The GSTT1 genotypes as a marker for susceptibility to lung cancer in Korean female never-smokers. Tuberc Respir Dis. 2003. 54:485–494.
30. Naoe T, TAkeyama K, Yolozawa T, Kiyoi H, Seto M, Uike N, Ino T, Utsunomiya A, Maruta A, Jin-nai I, kamata N, Kubota Y, Nakamura H, Shimazaki C, Horiike S, Kodera Y, Saito H, Ueda R, Wiemels J, Ohno R. Analysis of genetic polymorphism in NQ01, GSTM1, GSTT1, and CYP344 in 469 Japanese patients with therapy-related leukemic/myelodysplastic syndrome and de novo acute myeloid leukemia. Clin Cancer Res. 2000. 6:4091–4095.
31. Chen Cl, Liu Q, Relling MV. Simultaneous characterization of glutathione S-transferase M1 and T1 polymorphisms by polymerase chain reaction in American whites and blacks. Pharmacogenetics. 1996. 6(2):187–191.
32. Lee SH, Park E, Park YK. Glutathione S-Transferase M1 and T1 Polymorphisms and Susceptibility to Oxidative Damage in Healthy Korean Smokers. Ann Nutr Metab. 2010. 56(1):52–58.
33. Kim SJ, Kim MG, Kim KS, Song JS, Yim SV, Chung JH. Impact of glutathione S-transferase M1 and T1 gene polymorphisms on the smoking-related coronary artery disease. J Korean Med Sci. 2008. 23(3):365–372.
34. Yim JJ, Park GY, Lee CT, Kim YW, Han SK, Shim YS, Yoo CG. Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1. Thorax. 2000. 55(2):121–125.
35. Kim JH, Moon MK, Kim SW, Shin HD, Hwang YH, Ahn CR, Jang HC, Park KS, Kim SY, Lee HK. Glutathion S-Transferase M1 Gene Polymorphism is Associated with Type 2 Diabetic Nephropathy. J Korean Diabetes Assoc. 2005. 29(4):315–321.
36. Andersen HR, Nielsen JB, Nielsen F, Grandjean P. Antioxidative enzyme activities in human erythrocytes. Clin Chem. 1997. 43:562–568.
37. Dusinska M, Ficek A, Horska A, Raslova K, Petrovska H, Vallova B, Drlickova M, Wood SG, Stupakova A, Gasparovic J, Bobek P, Nagyova A, Kovacikova Z, Blazicek P, Liegebel U, Collins AR. Glutathione S-transferase polymorphisms influence the level of oxidative DNA damage and antioxidant protection in humans. Mutat Res. 2001. 482:47–55.
38. Bessa SS, Ali EM, Hamdy SM. The role of glutathione S-trasferase M1 and T1 gene polymorphisms and oxidative stress-related parameters in Egyptian patients with essential hypertension. Eur J Intern Med. 2009. 20(6):625–630.
39. Kang MH, Yun JS. The effects of exercise and other relating factors on the activity of erythrocyte antioxidant enzymes and plasma TRAP levels in male college students. Korean J Nutr. 2002. 35(1):30–36.
41. Horska A, Mislanova C, Bonassi S, Ceppi M, Volkovova K, Dusinska M. Vitamin C levels in blood are influenced by polymorphisms in glutathione S-transferases. Eur J Nutr. 2010. published online 09 December.
42. Rojas E, Valverde M, Sordo M, Ostrosky-Wegman P. DNA damage in exfoliated buccal cells of smokers assed by the single cell gel electrophoresis assay. Mutat Res. 1996. 370(2):115–120.
43. Park EJ, Kang MH. Application of the alkaline comet assay for detecting oxidative DNA damage in human monitoring. Korean J Nutr. 2002. 35(2):213–222.
44. Hong YC, Lee KH, Yi CH, Ha EH, Christiani DC. Genetic susceptibility of term pregnant women to oxidative damage. Toxicol Lett. 2002. 129:255–262.
45. Steinberg ML, Hubbard K, Utti C, Clas B, Hwang BJ, Hill HZ, Orlow I. Patterns of persistent DNA damage associated with sun exposure and the glutathione S-transferase M1 genotype in melanoma patients. Photochem Photobiol. 2009. 85:379–386.